• 1
    Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995;310:12251228.
  • 2
    Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982986.
  • 3
    Silverman M, Wilson N. Wheezing phenotypes in childhood. Thorax 1997;52:936937.
  • 4
    Papadopoulos NG, Velissariou I. The role of respiratory viruses in the pathogenesis of pediatric asthma. Pediatr Ann 2006;35:637642.
  • 5
    Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol 2004;113:S814.
  • 6
    Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549557.
  • 7
    Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181:18751884.
  • 8
    Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol 2006;34:192203.
  • 9
    Bardin PG, Fraenkel DJ, Sanderson G, Van Schalkwyk EM, Holgate ST, Johnston SL. Peak expiratory flow changes during experimental rhinovirus infection. Eur Respir J 2000;16:980985.
  • 10
    Fleming HE, Little FF, Schnurr D, Avila PC, Wong H, Liu J et al. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999;160:100108.
  • 11
    Grunberg K, Timmers M, Smits H, De Klerk E, Dick E, Spaan W et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997;27:3645.
  • 12
    Grunberg K, Timmers MC, De Klerk EP, Dick EC, Sterk PJ. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999;160:13751380.
  • 13
    Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831834.
  • 14
    Malmstrom K, Pitkaranta A, Carpen O, Pelkonen A, Malmberg LP, Turpeinen M et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006;118:591596.
  • 15
    Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998;157:17081720.
  • 16
    Dakhama A, Lee YM, Gelfand EW. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J 2005;24:S159169.
  • 17
    Hegele RG, Hayashi S, Hogg JC, Pare PD. Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections. Am J Respir Crit Care Med 1995;151:16591664.
  • 18
    Grunberg K, Smits H, Timmers M, De Klerk E, Dolhain R, Dick E et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609616.
  • 19
    Park JW, Taube C, Yang ES, Joetham A, Balhorn A, Takeda K et al. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. J Allergy Clin Immunol 2003;112:10781087.
  • 20
    Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Makela MJ, Dakhama A et al. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med 2000;162:380386.
  • 21
    Schwarze J, Gelfand EW. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur Respir J 2002;19:341349.
  • 22
    Cheung D, Dick EC, Timmers MC, De Klerk EP, Spaan WJ, Sterk PJ. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995;152:14901496.
  • 23
    Gern JE, Calhoun W, Swenson C, Shen G, Busse WW. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997;155:18721876.
  • 24
    Calhoun W, Dick E, Schwartz L, Busse W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:22002208.
  • 25
    Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989;83:110.
  • 26
    Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003;111:215225; quiz 226.
  • 27
    Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004;189:18561865.
  • 28
    Xepapadaki P, Papadopoulos NG, Bossios A, Manoussakis E, Manousakas T, Saxoni-Papageorgiou P. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 2005;116:299304.
  • 29
    O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest 2003;123:411S-416S.
  • 30
    Matsuse H, Behera AK, Kumar M, Rabb H, Lockey RF, Mohapatra SS. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol 2000;164:65836592.
  • 31
    Bossios A, Psarras S, Gourgiotis D, Skevaki CL, Constantopoulos AG, Saxoni-Papageorgiou P et al. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 2005;6:114.
  • 32
    Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780793.
  • 33
    Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 1999;274:97079720.
  • 34
    Papi A, Johnston SL. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-kappaB and GATA transcription factors. J Biol Chem 1999;274:3004130051.
  • 35
    Papi A, Stanciu LA, Papadopoulos NG, Teran LM, Holgate ST, Johnston SL. Rhinovirus infection induces major histocompatibility complex class I and costimulatory molecule upregulation on respiratory epithelial cells. J Infect Dis 2000;181:17801784.
  • 36
    Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004;1:9398.
  • 37
    Vignola AM, Gagliardo R, Siena A, Chiappara G, Bonsignore MR, Bousquet J et al. Airway remodeling in the pathogenesis of asthma. Curr Allergy Asthma Rep 2001;1:108115.
  • 38
    Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937947.
  • 39
    Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006;12:10231026.
  • 40
    Hakonarson H, Maskeri N, Carter C, Hodinka RL, Campbell D, Grunstein MM. Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J Clin Invest 1998;102:17321741.
  • 41
    Furukawa E, Ohrui T, Yamaya M, Suzuki T, Nakasato H, Sasaki T et al. Human airway submucosal glands augment eosinophil chemotaxis during rhinovirus infection. Clin Exp Allergy 2004;34:704711.
  • 42
    Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002;110:165175.
  • 43
    Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 2004;170:306312.
  • 44
    Hiu IJ, Liepkalns V, Azzarone B, Macieira-Coelho A. Metabolic changes in fibroblast adhesion sites induced by growth factors. Cell Biol Int Rep 1985;9:379387.
  • 45
    Psarras S, Xatzipsalti M, Volonaki E, Bossios A, Gourgiotis D, Saxoni-Papageorgiou F et al. Rhinovirus infection stimulates production of fibroblast growth factor-2 by airway epithelial and stromal cells. Allergy 2002;57:S28.
  • 46
    Lee CG, Yoon HJ, Zhu Z, Link H, Wang Z, Gwaltney JM et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 2000;23:662669.
  • 47
    Psarras S, Volonaki E, Skevaki CL, Xatzipsalti M, Bossios A, Pratsinis H et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol 2006;117:291297.
  • 48
    Yeo SJ, Yun YJ, Lyu MA, Woo SY, Woo ER, Kim SJ et al. Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. Arch Virol 2002;147:229242.
  • 49
    Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428432.
  • 50
    Arnold R, Humbert B, Werchau H, Gallati H, Konig W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994;82:126133.
  • 51
    Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002;19:6875.
  • 52
    Schuster A, Fahy JV, Ueki I, Nadel JA. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur Respir J 1995;8:1014.
  • 53
    Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843852.
  • 54
    Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000;105:11691177.
  • 55
    Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000;162:22262231.
  • 56
    Folkerts G, Nijkamp FP. Virus-induced airway hyperresponsiveness. Role of inflammatory cells and mediators. Am J Respir Crit Care Med 1995;151:16661673.
  • 57
    Busse WW, Vrtis RF, Steiner R, Dick EC. In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide. Am J Respir Cell Mol Biol 1991;4:347354.
  • 58
    Wark PA, Gibson PG, Johnston SL. Exacerbations of asthma: addressing the triggers and treatments. Monaldi Arch Chest Dis 2001;56:429435.
  • 59
    Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879886.
  • 60
    Grunberg K, Sharon RF, Sont JK, In ‘t Veen JC, Van Schadewijk WA, De Klerk EP et al. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001;164:18161822.
  • 61
    Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Lee WM, Kelly EA et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998;160:12791284.
  • 62
    Gern J, Vrtis R, Kelly E, Dick E, Busse W. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 1996;157:16051612.
  • 63
    Garofalo R, Kimpen JL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992;120:2832.
  • 64
    Heymann P, Rakes G, Hogan A, Ingram J, Hoover G, Platts-Mills T. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. Int Arch Allergy Immunol 1995;107:380382.
  • 65
    Teran LM, Seminario MC, Shute JK, Papi A, Compton SJ, Low JL et al. RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis 1999;179:677681.
  • 66
    Clementsen P, Kristensen KS, Norn S. Virus, bacteria and lipopolysaccharide increase basophil cell response to histamine releasing stimulators and calcium. Examination of allergic and normal individuals. Allergy 1991;46:135141.
  • 67
    Lavens SE, Goldring K, Thomas LH, Warner JA. Effects of integrin clustering on human lung mast cells and basophils. Am J Respir Cell Mol Biol 1996;14:95103.
  • 68
    Ida S, Hooks JJ, Siraganian RP, Notkins AL. Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med 1977;145:892906.
  • 69
    Makela MJ, Halminen M, Ruuskanen O, Puhakka T, Pirhonen J, Julkunen I et al. Lack of induction by rhinoviruses of systemic type I interferon production or enhanced MxA protein expression during the common cold. Eur J Clin Microbiol Infect Dis 1999;18:665668.
  • 70
    Ogunbiyi PO, Black WD, Eyre P. Parainfluenza-3 virus-induced enhancement of histamine release from calf lung mast cells – effect of levamisole. J Vet Pharmacol Ther 1988;11:338344.
  • 71
    Sorden SD, Castleman WL. Virus-induced increases in airway mast cells in brown Norway rats are associated with enhanced pulmonary viral replication and persisting lymphocytic infiltration. Exp Lung Res 1995;21:197213.
  • 72
    Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:15291531.
  • 73
    Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004;103:14331437.
  • 74
    Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987995.
  • 75
    Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol 2006;35:387393.
  • 76
    Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003;171:31543162.
  • 77
    Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002;195:15071512.
  • 78
    Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005;79:1227312279.
  • 79
    Schlender J, Hornung V, Finke S, Gunthner-Biller M, Marozin S, Brzozka K et al. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 2005;79:55075515.
  • 80
    Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 2006;203:13991405.
  • 81
    Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 2005;172:530551.
  • 82
    O'Sullivan S, Cormican L, Faul JL, Ichinohe S, Johnston SL, Burke CM et al. Activated, cytotoxic CD8+ T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med 2001;164:560564.
  • 83
    O'Sullivan SM. Asthma death, CD8+ T cells, and viruses. Proc Am Thorac Soc 2005;2:162165.
  • 84
    Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994;180:12731282.
  • 85
    Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002;57:328332.
  • 86
    Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. Rhinovirus-induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects. Clin Exp Allergy 2002;32:537542.
  • 87
    Message SD, Johnston SL. The immunology of virus infection in asthma. Eur Respir J 2001;18:10131025.
  • 88
    Fabbri LM, De Rose V, Godard P, Rossi GA. Clinical guidelines and indications for bronchoalveolar lavage (BAL): bronchial asthma. Eur Respir J 1990;3:961969.
  • 89
    Rennard SI, Aalbers R, Bleecker E, Klech H, Rosenwasser L, Olivieri D et al. Bronchoalveolar lavage: performance, sampling procedure, processing and assessment. Eur Respir J Suppl 1998;26:13S-15S.
  • 90
    Gern JE, Dick EC, Lee WM, Murray S, Meyer K, Handzel ZT et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996;156:621627.
  • 91
    Johnston SL, Papi A, Monick MM, Hunninghake GW. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 1997;175:323329.
  • 92
    Laza-Stanca V, Stanciu LA, Message SD, Edwards MR, Gern JE, Johnston SL. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 2006;80:82488258.
  • 93
    Donninger H, Glashoff R, Haitchi HM, Syce JA, Ghildyal R, Van Rensburg E et al. Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. J Infect Dis 2003;187:18091817.
  • 94
    Einarsson O, Geba G, Zhu Z, Landry M, Elias J. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996;97:915924.
  • 95
    Funkhouser AW, Kang JA, Tan A, Li J, Zhou L, Abe MK et al. Rhinovirus 16 3C protease induces interleukin-8 and granulocyte-macrophage colony-stimulating factor expression in human bronchial epithelial cells. Pediatr Res 2004;55:1318.
  • 96
    Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno S, Busse WW. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 2003;28:731737.
  • 97
    Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998;160:61726181.
  • 98
    Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2001;31:10601066.
  • 99
    Schroth MK, Grimm E, Frindt P, Galagan DM, Konno SI, Love R et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 1999;20:12201228.
  • 100
    Terajima M, Yamaya M, Sekizawa K, Okinaga S, Suzuki T, Yamada N et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol 1997;273:L749759.
  • 101
    Yamaya M, Sekizawa K, Suzuki T, Yamada N, Furukawa M, Ishizuka S et al. Infection of human respiratory submucosal glands with rhinovirus: effects on cytokine and ICAM-1 production. Am J Physiol 1999;277:L362371.
  • 102
    De Kluijver J, Grunberg K, Pons D, De Klerk EP, Dick CR, Sterk PJ et al. Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy 2003;33:14151418.
  • 103
    Greiff L, Andersson M, Andersson E, Linden M, Myint S, Svensson C et al. Experimental common cold increases mucosal output of eotaxin in atopic individuals. Allergy 1999;54:12041208.
  • 104
    Greiff L, Venge P, Andersson M, Enander I, Linden M, Myint S et al. Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. J Infect 2002;45:227232.
  • 105
    Seymour ML, Gilby N, Bardin PG, Fraenkel DJ, Sanderson G, Penrose JF et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 2002;185:540544.
  • 106
    De Gouw HW, Grunberg K, Schot R, Kroes AC, Dick EC, Sterk PJ. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998;11:126132.
  • 107
    Proud D. The role of defensins in virus-induced asthma. Curr Allergy Asthma Rep 2006;6:8185.
  • 108
    Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004;114:S135138.
  • 109
    Beisswenger C, Platz J, Seifart C, Vogelmeier C, Bals R. Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration 2004;71:402409.
  • 110
    Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513521.
  • 111
    Steerenberg PA, Zonnenberg JA, Dormans JA, Joon PN, Wouters IM, Van Bree L et al. Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS 2B) in vitro. Exp Lung Res 1998;24:85100.
  • 112
    Wang XP, Schunck M, Kallen KJ, Neumann C, Trautwein C, Rose-John S et al. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 2004;123:124131.
  • 113
    Naclerio R, Proud D, Lichtenstein L, Kagey-Sobotka A, Hendley J, Sorrentino J et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988;157:133142.
  • 114
    Proud D, Gwaltney JMJ, Hendley J, Dinarello C, Gillis S, Schleimer R. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994;169:10071013.
  • 115
    Tanaka H, Miyazaki N, Oashi K, Teramoto S, Shiratori M, Hashimoto M et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001;107:331336.
  • 116
    Turner RB, Weingand KW, Yeh CH, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds [see comments]. Clin Infect Dis 1998;26:840846.
  • 117
    Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT et al. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 1987;82:238243.
  • 118
    Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 1986;22:669676.
  • 119
    Jacoby DB. Virus-induced asthma attacks. JAMA 2002;287:755761.
  • 120
    Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469476.
  • 121
    Jacoby DB, Tamaoki J, Borson DB, Nadel JA. Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase. J Appl Physiol 1988;64:26532658.
  • 122
    Auais A, Adkins B, Napchan G, Piedimonte G. Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats. Am J Physiol Lung Cell Mol Physiol 2003;285:L105113.
  • 123
    Tripp RA, Barskey A, Goss L, Anderson LJ. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J Neuroimmunol 2002;129:141153.
  • 124
    Tripp RA, Jones L, Anderson LJ. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 2000;74:62276229.
  • 125
    King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 2001;24:101107.
  • 126
    Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 1999;277:L831840.
  • 127
    Colasurdo GN, Hemming VG, Prince GA, Loader JE, Graves JP, Larsen GL. Human respiratory syncytial virus affects nonadrenergic noncholinergic inhibition in cotton rat airways. Am J Physiol 1995;268:L10061011.
  • 128
    Dusser DJ, Jacoby DB, Djokic TD, Rubinstein I, Borson DB, Nadel JA. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 1989;67:15041511.
  • 129
    Nakazawa H, Sekizawa K, Morikawa M, Yamauchi K, Satoh M, Maeyama K et al. Viral respiratory infection causes airway hyperresponsiveness and decreases histamine N-methyltransferase activity in guinea pigs. Am J Respir Crit Care Med 1994;149:11801185.
  • 130
    Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131139.
  • 131
    Anderson GP. Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol 2006;31:119130.
  • 132
    Buckner CK, Clayton DE, Ain-Shoka AA, Busse WW, Dick EC, Shult P. Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest 1981;67:376384.
  • 133
    Uetani K, Arroliga ME, Erzurum SC. Double-stranded rna dependence of nitric oxide synthase 2 expression in human bronchial epithelial cell lines BET-1A and BEAS-2B. Am J Respir Cell Mol Biol 2001;24:720726.
  • 134
    Bitko V, Velazquez A, Yang L, Yang YC, Barik S. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 1997;232:369378.
  • 135
    Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D. Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000;165:33843392.
  • 136
    Papi A, Papadopoulos NG, Stanciu LA, Bellettato CM, Pinamonti S, Degitz K et al. Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells. FASEB J 2002;16:19341936.
  • 137
    Newcomb DC, Sajjan U, Nanua S, Jia Y, Goldsmith AM, Bentley JK et al. Phosphatidylinositol 3-kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression. J Biol Chem 2005;280:3695236961.
  • 138
    Griego SD, Weston CB, Adams JL, Tal-Singer R, Dillon SB. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 2000;165:52115220.
  • 139
    Dumitru CA, Dreschers S, Gulbins E. Rhinoviral infections activate p38MAP-kinases via membrane rafts and RhoA. Cell Physiol Biochem 2006;17:159166.
  • 140
    Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006;193:438441.
  • 141
    Hoebee B, Bont L, Rietveld E, Van Oosten M, Hodemaekers HM, Nagelkerke NJ et al. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis 2004;189:239247.
  • 142
    Heinzmann A, Ahlert I, Kurz T, Berner R, Deichmann KA. Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2004;114:671676.
  • 143
    Bardin PG, Fraenkel DJ, Sanderson G, Dorward M, Lau LC, Johnston SL et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 1994;24:457464.
  • 144
    Zambrano JC, Carper HT, Rakes GP, Patrie J, Murphy DD, Platts-Mills TAE et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol 2003;111:1008.
  • 145
    Rakes Gary P, Arruda E, Ingram Jim M, Hoover Gates E, Zambrano Juan C, Hayden Frederick G et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999;159:785790.
  • 146
    Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763766.
  • 147
    Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376382.
  • 148
    De Kluijver J, Evertse CE, Sont JK, Schrumpf JA, Zeijl-van der Ham CJG, Dick CR et al. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure? Am J Respir Crit Care Med 2003;168:11741180.
  • 149
    Avila PC, Abisheganaden JA, Wong H, Liu J, Yagi S, Schnurr D et al. Effects of allergic inflammation of thenasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 2000;105:923.
  • 150
    Bossios A, Psarras S, Gourgiotis D, Stavrinadis C, Saxoni-Papageorgiou P, Papadopoulos NG. Infection with human rhinovirus and exposure to Der p I synergize in ICAM-1 expression and IL-8 production by airway epithelial cells. XXIII Congress of European Academy of Allergology and Clinical Immunology, Amsterdam, 2004.
  • 151
    Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ et al. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation. J Infect Dis 2004;189:18661872.
  • 152
    Ezzati M, Kammen DM. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet 2001;358:619.
  • 153
    Touloumi G, Katsouyanni K, Zmirou D, Schwartz J, Spix C, De Leon AP et al. Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air Pollution and Health: a European Approach. Am J Epidemiol 1997;146:177185.
  • 154
    Pilotto LS, Douglas RM, Attewell RG, Wilson SR. Respiratory effects associated with indoor nitrogen dioxide exposure in children. Int J Epidemiol 1997;26:788796.
  • 155
    Chauhan AJ, Inskip HM, Linaker CH, Smith S, Schreiber J, Johnston SL et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet 2003;361:1939.
  • 156
    Harrod KS, Jaramillo RJ, Rosenberger CL, Wang SZ, Berger JA, McDonald JD et al. Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions. Am J Respir Cell Mol Biol 2003;28:451463.
  • 157
    Ito T, Okumura H, Tsukue N, Kobayashi T, Honda K, Sekizawa K. Effect of diesel exhaust particles on mRNA expression of viral and bacterial receptors in rat lung epithelial L2 cells. Toxicol Lett 2006;165:6670.
  • 158
    Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE et al. Active and passive smoking and risk of colds in women. Ann Epidemiol 2001;11:225.
  • 159
    Cohen S, Tyrrell DA, Russell MA, Jarvis MJ, Smith AP. Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 1993;83:12771283.
  • 160
    Cunningham J, O'Connor GT, Dockery DW, Speizer FE. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med 1996;153:218224.
  • 161
    Venarske DL, Busse WW, Griffin MR, Gebretsadik T, Shintani AK, Minton PA et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006;193:15361543.
  • 162
    Franklin PJ, Turner S, Mutch R, Stick SM. Parental smoking increases exhaled nitric oxide in young children. Eur Respir J 2006;28:730733.